Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors
NCT02930993
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Mesothelin Positive Tumors
Interventions
BIOLOGICAL:
anti-mesothelin CAR T cells
Sponsor
China Meitan General Hospital
Collaborators
[object Object]